CN106860728A - A kind of reflux esophagitis medicine - Google Patents
A kind of reflux esophagitis medicine Download PDFInfo
- Publication number
- CN106860728A CN106860728A CN201510930109.XA CN201510930109A CN106860728A CN 106860728 A CN106860728 A CN 106860728A CN 201510930109 A CN201510930109 A CN 201510930109A CN 106860728 A CN106860728 A CN 106860728A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- reflux esophagitis
- chinese
- herb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a kind of reflux esophagitis medicine, the medicine includes the composition of following weight portion：9 parts of Androsace umbellata, 6 parts of common claoxylon root and leaf, 6 parts of drop of water, 3 parts of Chinese artichoke, 1 part of pilosella-leaved drymoglossum herb, 1 part of lotus seeds, 0.5 part of Whitebackleaf Mallotus Root, 0.5 part of caulis clematidis armandii.The pink reineckea herb of the greater celandine, the Thesium chinese of 2 weight portions or 1 weight portion of 2 weight portions can also be further added on this basis.The present invention has obtained above pharmaceutical formulation by the rational Design on Plane to traditional Chinese medicine ingredients, and the medicine protrudes reflux esophagitis curative effect, works comparatively fast, and efficient and cure rate is superior to prior art.
Description
Technical field
The present invention relates to medical sanitary technology field, and in particular to a kind of reflux esophagitis medicine.
Background technology
Reflux esophagitis (RE) is to enter the esophagitis venereal disease change that oesophagus causes by Stomach duodenum content reflux, and Endoscopic Features are the breakage of Esophageal Mucosa, i.e. oesophagus erosion and (or) esophageal ulcer.Reflux esophagitis can betide the crowd at any age, and Adult Onset leads and increases and raise with the age.The Hesperian incidence of disease is high, and the Asia incidence of disease is low.This geographic difference may be relevant with h and E factor.But the incidence of disease in the recent two decades whole world is all on the rise.The elderly, obesity, smoking, drink and stress be greatly reflux esophagitis group of people at high risk.The reflux esophagitis medicine of prior art has unsatisfactory curative effect, work slower technical problem, so as to significantly limit the therapeutic effect of the disease.
The content of the invention
It is contemplated that for the technological deficiency of prior art, there is provided a kind of reflux esophagitis medicine, to solve the slower technical problem of reflux esophagitis medicine unsatisfactory curative effect, action in the prior art.
To realize above technical purpose, the present invention uses following technical scheme：
A kind of reflux esophagitis medicine, including following weight portion composition：9 parts of Androsace umbellata, 6 parts of common claoxylon root and leaf, 6 parts of drop of water, 3 parts of Chinese artichoke, 1 part of pilosella-leaved drymoglossum herb, 1 part of lotus seeds, 0.5 part of Whitebackleaf Mallotus Root, 0.5 part of caulis clematidis armandii.
Preferably, also including the greater celandine of 2 weight portions.
Preferably, also including the Thesium chinese of 2 weight portions.
Preferably, also including the pink reineckea herb of 1 weight portion.
Preferably, the formulation of the medicine is powder.
Preferably, the formulation of the medicine is pill.
The present invention is by the rational Design on Plane to traditional Chinese medicine ingredients, above pharmaceutical formulation is obtained, mentioned component respectively has the pharmacological properties of its own, although not finding that mentioned component individually has therapeutic effect to reflux esophagitis in the prior art, but the present invention is found surprisingly that after being integrated and optimizing consumption proportion, resulting pharmaceutical composition has prominent therapeutic effect to reflux esophagitis, while working very fast and having no side effect.Positive discovery, develops reflux esophagitis medicine of the invention based on more than, and its determined curative effect, clinical trial work well, great industrialization prospect.
Specific embodiment
Specific embodiment of the invention will be below described in detail.In order to avoid excessive unnecessary details, be will not be described in detail to belonging to known structure or function in the examples below.In addition to being defined, technology used and scientific terminology have the identical meanings being commonly understood by with those skilled in the art of the invention in following examples.
Embodiment 1
A kind of reflux esophagitis medicine, is composed of the following components in parts by weight：9 parts of Androsace umbellata, 6 parts of common claoxylon root and leaf, 6 parts of drop of water, 3 parts of Chinese artichoke, 1 part of pilosella-leaved drymoglossum herb, 1 part of lotus seeds, 0.5 part of Whitebackleaf Mallotus Root, 0.5 part of caulis clematidis armandii, 2 parts of greater celandine, 2 parts of Thesium chinese, 1 part of pink reineckea herb.Its formulation is powder.
Embodiment 2
A kind of reflux esophagitis medicine, is composed of the following components in parts by weight：9 parts of Androsace umbellata, 6 parts of common claoxylon root and leaf, 6 parts of drop of water, 3 parts of Chinese artichoke, 1 part of pilosella-leaved drymoglossum herb, 1 part of lotus seeds, 0.5 part of Whitebackleaf Mallotus Root, 0.5 part of caulis clematidis armandii, 2 parts of greater celandine, 1 part of pink reineckea herb.Its formulation is pill.
Embodiment 3
A kind of reflux esophagitis medicine, is composed of the following components in parts by weight：9 parts of Androsace umbellata, 6 parts of common claoxylon root and leaf, 6 parts of drop of water, 3 parts of Chinese artichoke, 1 part of pilosella-leaved drymoglossum herb, 1 part of lotus seeds, 0.5 part of Whitebackleaf Mallotus Root, 0.5 part of caulis clematidis armandii, 2 parts of Thesium chinese, 1 part of pink reineckea herb.Its formulation is pill.
Embodiment 4
A kind of reflux esophagitis medicine, is composed of the following components in parts by weight：9 parts of Androsace umbellata, 6 parts of common claoxylon root and leaf, 6 parts of drop of water, 3 parts of Chinese artichoke, 1 part of pilosella-leaved drymoglossum herb, 1 part of lotus seeds, 0.5 part of Whitebackleaf Mallotus Root, 0.5 part of caulis clematidis armandii, 2 parts of greater celandine.Its formulation is powder.
Embodiment 5
A kind of reflux esophagitis medicine, is composed of the following components in parts by weight：9 parts of Androsace umbellata, 6 parts of common claoxylon root and leaf, 6 parts of drop of water, 3 parts of Chinese artichoke, 1 part of pilosella-leaved drymoglossum herb, 1 part of lotus seeds, 0.5 part of Whitebackleaf Mallotus Root, 0.5 part of caulis clematidis armandii.
Embodiments of the invention have been described in detail above, but the content is only presently preferred embodiments of the present invention, is not intended to limit the invention.All any modification, equivalent and improvement made in application range of the invention etc., should be included within the scope of the present invention.
Claims (6)
1. a kind of reflux esophagitis medicine, it is characterised in that the composition including following weight portion：Point ground
9 parts of plum, 6 parts of common claoxylon root and leaf, 6 parts of drop of water, 3 parts of Chinese artichoke, 1 part of pilosella-leaved drymoglossum herb, 1 part of lotus seeds, the white back of the body
0.5 part of leaf, 0.5 part of caulis clematidis armandii.
2. medicine according to claim 1, it is characterised in that also including the greater celandine of 2 weight portions.
3. medicine according to claim 1, it is characterised in that also including the Thesium chinese of 2 weight portions.
4. medicine according to claim 1, it is characterised in that also including the pink reineckea herb of 1 weight portion.
5. medicine according to claim 1, it is characterised in that the formulation of the medicine is powder.
6. medicine according to claim 1, it is characterised in that the formulation of the medicine is pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510930109.XA CN106860728A (en) | 2015-12-14 | 2015-12-14 | A kind of reflux esophagitis medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510930109.XA CN106860728A (en) | 2015-12-14 | 2015-12-14 | A kind of reflux esophagitis medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106860728A true CN106860728A (en) | 2017-06-20 |
Family
ID=59239394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510930109.XA Pending CN106860728A (en) | 2015-12-14 | 2015-12-14 | A kind of reflux esophagitis medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106860728A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113797240A (en) * | 2021-10-21 | 2021-12-17 | 河南省纳普生物技术有限公司 | Application of total polyphenol extract of tung tree in preparation of calcium ion channel inhibiting medicine |
-
2015
- 2015-12-14 CN CN201510930109.XA patent/CN106860728A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113797240A (en) * | 2021-10-21 | 2021-12-17 | 河南省纳普生物技术有限公司 | Application of total polyphenol extract of tung tree in preparation of calcium ion channel inhibiting medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017100479A4 (en) | Traditional medicinal pillow | |
| CN107714845A (en) | A kind of pharmaceutical composition and its preparation and purposes | |
| CN106860728A (en) | A kind of reflux esophagitis medicine | |
| CN104800597A (en) | Traditional Chinese medicine composition for treating sphagitis | |
| CN105125708B (en) | A kind of pharmaceutical composition and preparation method thereof for rhinitis | |
| CN104013851B (en) | A kind of Chinese medicine preparation treating tinea pedis | |
| CN106860676A (en) | A kind of hypertension therapeutic medicine | |
| CN105456761A (en) | External-use composition for sleep improvement and preparation method thereof | |
| CN105560253A (en) | Use of compound triptolide in choroidal neovascularization | |
| CN106822530A (en) | A kind for the treatment of chronic pancreatitis medicine | |
| CN107397804A (en) | Hemorrhoid, dizziness, vigilance disorders rehabilitation composition caused by deficiency of qi and blood | |
| CN106860742A (en) | A kind of fatty liver medicine | |
| CN106860798A (en) | A kind of lupus erythematosus zhiliao medicine | |
| CN106822626A (en) | A kind for the treatment of of chronic medicine | |
| CN107334988B (en) | Traditional Chinese medicine composition for treating pulmonary abscess | |
| CN106860632A (en) | A kind of remedy for bronchial asthma thing | |
| CN106822383A (en) | A kind of dysmenorrhea treatment medicine | |
| CN106166180A (en) | A kind of Chinese medicine composition treating oral ulcer and application thereof | |
| CN106860716A (en) | A kind of hyperthyroidism medicine | |
| CN106880703A (en) | A kind of pulmonary emphysema medicine | |
| CN105521143A (en) | Chronic hepatitis treating agent | |
| CN106822379A (en) | A kind of drug for peptic ulcer thing | |
| CN106853162A (en) | A kind of angina pectoris treatment medicine | |
| CN104587210A (en) | Composition for treating gastric ulcer | |
| CN106860553A (en) | A kind of osteoporosis therapy medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170620 |